about
CXCR-4 Targeted, Short Wave Infrared (SWIR) Emitting Nanoprobes for Enhanced Deep Tissue Imaging and Micrometastatic Cancer Lesion Detection.Structural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albuminStabilizing Agents for Drug Nanocrystals: Effect on BioavailabilityA structure-based model for predicting serum albumin bindingAll-Purpose Containers? Lipid-Binding Protein - Drug InteractionsSite-specific albumination of a therapeutic protein with multi-subunit to prolong activity in vivoSite-specific fatty acid-conjugation to prolong protein half-life in vivoOrganic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate, Cebus apella.Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin.Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion.Development and characterization of small bispecific albumin-binding domains with high affinity for ErbB3.Investigation of cyanine dyes for in vivo optical imaging of altered mitochondrial membrane potential in tumors.Quantitative comparison of tumor delivery for multiple targeted nanoparticles simultaneously by multiplex ICP-MSCordycepin and N6-(2-hydroxyethyl)-adenosine from Cordyceps pruinosa and their interaction with human serum albuminHow does the pathophysiological context influence delivery of bone growth factors?Challenges and opportunities in absorption, distribution, metabolism, and excretion studies of therapeutic biologics.Synthesis and in vitro efficacy of MMP9-activated NanoDendrons.Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagentsTargeting the Endocannabinoid System for Neuroprotection: A (19)F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA.Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation.Analysis on the current status of targeted drug delivery to tumorsNanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions.Novel therapy based on camelid nanobodies.Interactive association of drugs binding to human serum albumin.Promises and pitfalls of intracellular delivery of proteins.Albumin and its application in drug delivery.Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy.Polymersomes and their applications in cancer delivery and therapy.Self-Assembled Smart Nanocarriers for Targeted Drug Delivery.Single-domain antibodies for biomedical applications.Application of albumin-based nanoparticles in the management of cancer.Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.Controlled release of BSA-linked cisplatin through a PepGel self-assembling peptide nanofiber hydrogel scaffold.Peptide-Based and Polypeptide-Based Gene Delivery Systems.Albumin nanostructures as advanced drug delivery systems.Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation.A polyphenylene dendrimer drug transporter with precisely positioned amphiphilic surface patches.Kinetics and efficiency of a methyl-carboxylated 5-Fluorouracil-bovine serum albumin adduct for targeted delivery.Serum albumin as a local therapeutic agent in cell therapy and tissue engineering.In vitro evaluation of doxorubicin-incorporated magnetic albumin nanospheres.
P2860
Q27330200-84074B88-453D-43F2-9302-6822ACFC944BQ27700781-BC40A625-E078-49E2-8EB5-A870216AB67CQ28076633-EFCEC4B2-8CD6-4A15-A698-41DA50156F30Q28541718-05010B29-0CF2-4DAB-88F9-9567AE5378D0Q28546452-23A819A7-F73C-4437-B825-352B503CFA3BQ30300201-8FDF3391-3EE0-4206-94C1-15EDA9990643Q30398229-0CD4C865-AB35-4362-A76F-175FAB4D5144Q33719235-847881FB-2EAF-4A46-8544-578B76CE1F30Q34186253-A0DE82E2-2726-46E9-8E7E-87E4B14B75C5Q34420356-C8F28228-A6CA-42FB-BECA-33049561EB9DQ34752052-3D3AAD31-B8AC-428F-B42C-23675D555987Q35000393-1267F0AA-EA04-4C01-BA6C-85BA53225B22Q35214069-59C6DACE-496F-4409-A8EE-A0547E3B5A25Q35219777-6EEC3648-F448-453D-8573-381D5F69A68CQ35463054-7C9492AF-BB84-4F27-8442-0CF3A299705CQ36331497-798EF413-E142-456B-8DB6-E760B40C6D93Q36775887-49170E97-B9ED-4177-BBB4-92685DA26D3AQ37393159-BE7F74D6-9F45-4D9E-B182-65651E9584D9Q37579319-E8B74ED4-E05F-4186-A640-D837C15D2ED4Q37619232-1D7A9AA4-BF7E-4893-926D-52D2471E48E1Q38026625-E5AD1BB1-9D1A-47C9-94D4-0E7A00225D95Q38136246-AD949827-4E2C-4C21-ACBF-41B6CA4389C2Q38151739-340B92FE-745A-4DFA-A2BF-5736CA7A835AQ38192435-3FF05F9E-B2B8-45A5-BCDD-0AA24D42C634Q38240926-4F2B0AB4-A4EA-401C-A6C7-9DB508098278Q38292087-7D3F6C5D-2944-4806-8758-03A7C86F67E5Q38542764-394FF67D-90E6-444D-9F91-A61F3636F718Q38578305-F2A17528-C359-4D83-8274-D4FA28D6229EQ38599130-FA84F94C-0722-4ED3-878F-46DC9DDF3016Q38628712-6003BF1A-8E1A-4F7F-A7C0-5A02DEA78BD4Q38649063-FCEC2F69-354F-4728-B0FD-188DECF581F4Q38685860-2C2D4625-905D-4F19-B95D-2E44435EDE89Q38730907-491A33CA-C95B-479D-AD87-39A70D66740FQ38747732-8BC7638F-74B6-4A9B-8972-67033D32023BQ38842596-7A5137CE-3290-43E0-8311-DBD72FF7D5B4Q38855416-94FA3C23-8306-4926-B954-6AFFE15BA3D6Q38960372-9EC72154-2D39-4283-9A1B-6B6F321382D3Q38995614-E9AD33FF-C194-4FB2-B001-2F66BCC43598Q39012336-E46E1AF0-1E43-4678-83A5-6DB0DB6D572CQ39024248-1D767E78-42CE-47A0-9474-6AC51E2DDC85
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical impact of serum proteins on drug delivery.
@en
Clinical impact of serum proteins on drug delivery.
@nl
type
label
Clinical impact of serum proteins on drug delivery.
@en
Clinical impact of serum proteins on drug delivery.
@nl
prefLabel
Clinical impact of serum proteins on drug delivery.
@en
Clinical impact of serum proteins on drug delivery.
@nl
P1476
Clinical impact of serum proteins on drug delivery.
@en
P2093
Bakheet Elsadek
Felix Kratz
P304
P356
10.1016/J.JCONREL.2011.11.028
P407
P577
2011-12-01T00:00:00Z